AMLX
Price
$3.43
Change
-$0.08 (-2.28%)
Updated
Apr 4 closing price
Capitalization
303.91M
31 days until earnings call
FOLD
Price
$7.50
Change
-$0.50 (-6.25%)
Updated
Apr 4 closing price
Capitalization
2.3B
30 days until earnings call
Ad is loading...

AMLX vs FOLD

Header iconAMLX vs FOLD Comparison
Open Charts AMLX vs FOLDBanner chart's image
Amylyx Pharmaceuticals
Price$3.43
Change-$0.08 (-2.28%)
Volume$914.19K
Capitalization303.91M
Amicus Therapeutics
Price$7.50
Change-$0.50 (-6.25%)
Volume$3.18M
Capitalization2.3B
AMLX vs FOLD Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. FOLD commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and FOLD is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (AMLX: $3.43 vs. FOLD: $7.50)
Brand notoriety: AMLX and FOLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 117% vs. FOLD: 122%
Market capitalization -- AMLX: $303.91M vs. FOLD: $2.3B
AMLX [@Biotechnology] is valued at $303.91M. FOLD’s [@Biotechnology] market capitalization is $2.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $283.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileFOLD’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • FOLD’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while FOLD’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 4 bearish.
  • FOLD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AMLX and FOLD are a good buy in the short-term.

Price Growth

AMLX (@Biotechnology) experienced а -6.28% price change this week, while FOLD (@Biotechnology) price change was -11.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.00%. For the same industry, the average monthly price growth was -16.69%, and the average quarterly price growth was -18.23%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 07, 2025.

FOLD is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-11.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FOLD($2.3B) has a higher market cap than AMLX($304M). AMLX YTD gains are higher at: -9.259 vs. FOLD (-20.382). FOLD has higher annual earnings (EBITDA): 29.4M vs. AMLX (-290.98M). FOLD has more cash in the bank: 250M vs. AMLX (177M). AMLX has less debt than FOLD: AMLX (1.98M) vs FOLD (444M). FOLD has higher revenues than AMLX: FOLD (528M) vs AMLX (87.4M).
AMLXFOLDAMLX / FOLD
Capitalization304M2.3B13%
EBITDA-290.98M29.4M-990%
Gain YTD-9.259-20.38245%
P/E Ratio2.69N/A-
Revenue87.4M528M17%
Total Cash177M250M71%
Total Debt1.98M444M0%
FUNDAMENTALS RATINGS
FOLD: Fundamental Ratings
FOLD
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXFOLD
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
69%
Momentum
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 5 days ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 7 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
74%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
77%
View a ticker or compare two or three
Ad is loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSGZX13.14-0.70
-5.06%
MassMutual Small Cap Gr Eq I
CSIEX70.49-4.15
-5.56%
Calvert Equity A
ALTFX121.68-7.66
-5.92%
AB Sustainable Global Thematic A
RYIAX104.02-6.68
-6.03%
Rydex Internet H
RYTNX234.87-32.03
-12.00%
Rydex S&P 500 2x Strategy H

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-2.28%
XOMAO - AMLX
68%
Closely correlated
-0.75%
IKNA - AMLX
54%
Loosely correlated
-5.83%
XOMAP - AMLX
51%
Loosely correlated
-0.54%
CRBU - AMLX
43%
Loosely correlated
-2.23%
JAZZ - AMLX
43%
Loosely correlated
-8.92%
More